It is unknown how and to what extent CXCR4 signaling affects lung fibrosis and whether the lack of an inhibitory effect on CXCR4 is one of the reasons for the failure of compound 18a to attenuate lung fibrosis. The gene discussed is CXCR4; the disease is pulmonary fibrosis.